Description
Taylor & Francis Disorders of the Prostate New Concepts and Developments 2004 Edition by Fouad K. Habib
It has become clear that scientific discoveries and technological advances leading to novel practices are occurring more quickly than they can be assessed by either clinical trials or scientific evaluation. Nonetheless, important breakthroughs have been made in the development of new treatments with significant implications for the management of benign prostatic hyperplasia and prostate cancer. Providing a broad scientific background, The Prostate: New Concepts and Developments covers topics ranging from basic biology to the regulatory mechanisms that control abnormal growth and progression to metastasis. The book includes coverage of issues concerning the medical management of prostate diseases such as gene therapy and immunotherapy. Internationally recognized experts summarize their knowledge and provide an extensive, up-to-date review of the etiology, diagnosis, prognosis, and treatment of BPH and prostate cancer.Combining clinical trial data with the personal experience of the contributors, the book reviews the advances in knowledge of the underlying mechanisms of proliferation and metastasis at the molecular level and charts the future for more effective modalities in the diagnosis and prognosis of prostate disease. A comprehensive and clearly written text, illustrated throughout, this is a welcome addition to the busy clinician's armamentarium. Table of contents :- Natural History of Benign Prostatic Hyperplasia, S.J. Jacobson, G.J. Girman, and M.M. LieberCellular and Molecular Mechanisms that Modulate Prostate Cancer Metastasis, C.S. Foster, V. Karavana, Y. Ke, and M.B.A. DjamgozGenetic Susceptibility to Prostate Cancer, O. CussenotMolecular Biology of Progression of Prostate Cancer, T. VisakorpiHuman Genetic Variation at Hormone-metabolic Loci and Prostate Cancer Risk, N.M. Makridakis, R.K. Ross, and J.K.V. ReichardtLigand-Dependent and Independent Activation of the Androgen Recpetor and Implications for Therapy, H. Klocker, Z. Culig, I. Eder, C. Nessler-Manardi, I. Iotova, A. Hobisch, and G. BartschEstrogen Receptor Beta in the Prostate, Z. Weihua, S. Makela, S. Nilsson, M. Warner, and J.-A. GustafssonVitamin D Deficiency Increases Risk of Prostate Cancer, P. Tuohimaa, M.H. Ahonen, M. Blauer, I. Laaksi, Y.-R. Lou, P. Martikainen, S. Meittinen, P. Pennanen, S. Purmonen, A. Vienonen, T. Ylikomi, and H. SyvalaA Novel Gene Therapeutic Strategy Co-Targeting Tumor Epithelium and Stoma, L.W.K. Chung, A. Law, H. Rhee, S. Matsubara, C.-L. Hsieh, M. Egawa, M.-S. Park, K. Koenenman, F. Yeung, and H.E. ZhauPathological Angiogenesis: Molecular Aspects and Therapeutic Approaches, D. MarmeProtein Kinases as Targets for Cancer Therapy, G. Tortora and F. CiardielloMonoclonal Antibodies in the Management of Prostate Cancer: An Update, M.I. Lampe, E. Oosterwijk, and P.F.A. MuldersContemporary Clinical Trials of Prostate Cancer Immunotherapy, K.S. Hafez and M.G. SandaAutocrine and Paracrine Mechanisms in the Development of Prostate Cancer, J. IsaacsClinical Uroselectivity, M.G. Wyllie